Mechanisms and diagnosis of myocardial ischemia in patients with intact coronary arteries

V.A. Skybchyk, Yu.P. Melen

References

1. Berry C. Stable coronary syndromes: the case for consolidating the nomenclature of stable ischemic heart disease // Circulation.– 2017.– Vol. 136.– P. 437–439. doi: 10.1161/circulationaha.117.028991.
2. Brainin P., Frestad D., Prescott E. The prognostic value of coronary endothelial and microvascular dysfunction in subjects with normal or non-obstructive coronary artery disease: A systematic review and meta-analysis // Int. J. Cardiol.– 2018.– Vol. 254.– P. 1–9. doi: 10.1016/j.ijcard.2017.10.052.
3. Cook C.M., Ahmad Y., Howard J.P. Impact of percutaneous revascularization on exercise hemodynamics in patients with stable coronary disease // J. Am. Coll. Cardiol.– 2018.– Vol. 72.– P. 970–83. doi: 10.1016/j.jacc.2018.06.033.
4. Crea F., Bairey Merz C.N., Beltrame J.F. The parallel tales of microvascular angina and heart failure with preserved ejection fraction: a paradigm shift // Eur. Heart J.– 2017.– Vol. 38. –P.473–477. doi: 10.1093/eurheartj/ehw461.
5. El Sabbagh A., Prasad M., Zack C.J. Highsensitivity troponin in patients with coronary artery endothelial dysfunction // J. Invasive. Cardiol.– 2018.– Vol. 30.– P. 406–410. doi: 10.1002/clc.20836.
6. Fihn S.D., Blankenship J.C., Alexander K.P. 2014 ACC/AHA/AATS/PCNA/SCAI/STS focused update of the guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology /American Heart Association Task Force on Practice Guidelines, and the American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons // J. Am. Coll. Cardiol.– 2014.– Vol. 64.– P. 929–949. doi: 10.1161/cir.0000000000000095.
7. Ford T.J., Corcoran D., Oldroyd K.G. Rationale and design of the British Heart Foundation (BHF) Coronary Microvascular Angina (CorMicA) stratified medicine clinical trial // Am. Heart J.–2018.– Vol. 201.– P. 86–94. doi: 10.1016/j.ahj.2018.03.010.
8. Ford T.J., Rocchiccioli P., Good R. Systemic microvascular dysfunction in microvascular and vasospastic angina // Eur. Heart J.– 2018.– Vol. 39.– P. 4086–4097. doi: 10.1093/eurheartj/ehy529.
9. Ford T.J., Stanley B., Good R. Stratified medical therapy using invasive coronary function testing in angina: the CorMicA trial // J. Am. Coll. Cardiol.– 2018.– Vol. 72.– P. 2841–2855. doi: 10.1016/j.jacc.2018.09.006.
10. Ford T.J., Stanley B., Sidik N. One-year outcomes of angina management guided by invasive coronary function testing (CorMicA) // J. Am. Coll. Cardiol. Intv.– 2020.– Vol. 13.– P. 33–45. doi: 10.1016/j.jcin.2019.11.001.
11. Jordan K.P., Timmis A., Croft P. Prognosis of undiagnosed chest pain: linked electronic health record cohort study // BMJ.–2017.– Vol. 357.– P. 1194. doi: 10.1136/bmj.j1194.
12. Kaski J.C., Crea F., Gersh B.J. et al. Reappraisal of ischemic heart disease // Circulation.–2018.– Vol. 138.– P. 1463–1480. doi: 10.1161/circulationaha.118.031373.
13. Knuuti J., Wijns W., Saraste A. 2019 ESC guidelines for the diagnosis and management of chronic coronary syndromes // Eur Heart J.– 2020.– Vol. 41.– P. 407–477. doi: 10.1007/s00059-020-04935.
14. Kunadian V., Chieffo A., Camici P. et al. EAPCI Expert Consensus Document on Ischaemia with Non-Obstructive Coronary Arteries in Collaboration with European Society of Cardiology Working Group on Coronary Pathophysiology & Microcirculation Endorsed by Coronary Vasomotor Disorders International Study Group // Eur. Heart J.– 2020.– Vol. 41 (37).– P. 3504–3520. doi: 10.1093/eurheartj/ehaa503. 
15. Lindemann H., Petrovic I., Hill S. Biopsyconfirmed endothelial cell activation in patients with coronary microvascular dysfunction // Coron. Artery Dis.– 2018.– Vol. 29.– P. 216–222. doi: 10.1097/mca.0000000000000599.
16. Modi B.N., Rahman H., Sherif S.A. Is heart rate response a reliable marker of adenosineinduced coronary hyperemia? // Int. J. Cardiovasc. Imaging.– 2018.– Vol. 34.– P. 1117–1125. doi: 10.1007/s10554-018-1309-1.
17. Murthy V.L., Naya M., Taqueti V.R. Effects of sex on coronary microvascular dysfunction and cardiac outcomes // Circulation.– 2014.– Vol. 129.– P. 2518–2527. doi: 10.1161/circulationaha.113.008507.
18. Neumann F.J., Sousa-Uva M., Ahlsson A. 2018 ESC/EACTS guidelines on myocardial revascularization // Eur. Heart J.– 2019.– Vol. 40.– P. 87–165. doi: 10.1093/eurheartj/ehy855.
19. Ohyama K., Matsumoto Y., Takanami K. Coronary adventitial and perivascular adipose tissue inflammation in patients with vasospastic angina // J. Am. Coll. Cardiol.–2018.– Vol. 71.– P. 414–425. doi: 10.1016/j.jacc.2017.11.046.
20. Ong P., Athanasiadis A., Borgulya G. Clinical usefulness, angiographic characteristics, and safety evaluation of intracoronary acetylcholine provocation testing among 921 consecutive white patients with unobstructed coronary arteries // Circulation.– 2014.– Vol. 129.– P. 1723–1730. doi: 10.1161/circulationaha.113.004096.
21. Ong P., Camici P.G., Beltrame J.F. International standardization of diagnostic criteria for microvascular angina // Int. J. Cardiol.– 2018.– Vol. 250.– P. 16–20. doi: 10.1016/j.ijcard.2017.08.068.
22. Rahman H., Ryan M., Lumley M. Coronary microvascular dysfunction is associated with myocardial ischemia and abnormal coronary perfusion during exercise // Circulation.– 2019.–Vol. 140.– P. 1805–1816. doi: 10.1161/circulationaha.119.041595.
23. Reriani M., Flammer A.J., Duhe J. Coronary endothelial function testing may improve longterm quality of life in subjects with microvascular coronary endothelial dysfunction // Open. Heart.– 2019.– Vol. 6.– P. 870. doi: 10.1136/openhrt-2018-000870.
24. Roth G.A., Abate D., Abate K.H. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories 1980–2017: a systematic analysis for the Global Burden of Disease Study // Lancet.– 2017.– Vol. 392.– P. 1736–1788. doi: 10.1016/s0140-6736(14)61682-2.
25. Sara J.D.S., Corban M.T., Prasad M. The prevalence of myocardial bridging associated with coronary endothelial dysfunction in patients with chest pain and non-obstructive coronary artery disease // EuroIntervention.– 2020.– Vol. 15.– P. 1262–1268. doi: 10.4244/eij-d-18-00920.
26. Sechtem U., Brown D.L., Godo S. et al. Coronary microvascular dysfunction in stable ischaemic heart disease (non-obstructive coronary artery disease and obstructive coronary artery disease) // Cardiovasc Res.– 2020.– Vol. 116.– P. 771–786. doi: 10.1093/cvr/cvaa005.
27. Solberg O.G., Ragnarsson A., Kvarsnes A. Reference interval for the index of coronary microvascular resistance // EuroIntervention.– 2014.– Vol. 9.– P. 1069–1075. doi: 10.4244/eijv9i9a181.
28. Suda A., Takahashi J., Hao K. Coronary functional abnormalities in patients with angina and nonobstructive coronary artery disease // J. Am. Coll. Cardiol.– 2019.– Vol. 74.– P. 2350–2360. doi: 10.1016/j.jacc.2019.08.1056.
29. Sueda S., Miyoshi T., Sasaki Y. et al. Gender differences in sensitivity of acetylcholine and ergonovine to coronary spasm provocation test // Heart Vessels.– 2016.– Vol. 31.– P. 322–329. doi: 10.1007/s00380-014-0614-4.
30. Taqueti V.R., Di Carli M.F. Coronary microvascular disease pathogenic mechanisms and therapeutic options // J. Am. Coll. Cardiol.– 2018.– Vol. 72.– P. 2625–2641. doi: 10.1016/j.jacc.2018.09.042.
31. Taqueti V.R., Shaw L.J., Cook N.R. Excess cardiovascular risk in women relative to men referred for coronary angiography is associated with severely impaired coronary flow reserve, not obstructive disease // Circulation.– 2017.– Vol. 135.– P. 566–577. doi: 10.1161/circulationaha.116.023266.
32. Task Force M., Montalescot G., Sechtem U. 2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the Management of Stable Coronary Artery Disease of the European Society of Cardiology // Eur. Heart J.– 2013.– Vol. 34.– P. 2949–3003. doi: 10.1093/eurheartj/eht296.
33. Tavella R., Cutri N., Tucker G. et al. Natural history of patients with insignificant coronary artery disease // Eur. Heart J. Qual. Care Clin. Outcomes.– 2016.– Vol. 2.– P. 117–124. doi: 10.1093/ehjqcco/qcv034.
34. Widmer R.J., Samuels B., Samady H. The functional assessment of patients with nonobstructive coronary artery disease: expert review from an international microcirculation working group // EuroIntervention.– 2019.– Vol. 14.– P. 1694–1702. doi: 10.4244/eij-d-18-00982.
35. Williams R.P., de Waard G.A., De Silva K. Doppler versus thermodilution-derived coronary microvascular resistance to predict coronary microvascular dysfunction in patients with acute myocardial infarction or stable angina pectoris // Am. J. Cardiol.– 2018.– Vol. 121.– P. 1–8. doi: 10.1016/j.amjcard.2017.09.012.